Skip to Navigation Skip to Search Skip to Content
Search All Centers

MPN Headlines From ASH 2018 With Dr. Casey O’Connell

Read Transcript Download/Print Transcript

Published on December 16, 2018

As part of our coverage of the 2018 American Society of Hematology (ASH) Annual Meeting, Dr. Casey L. O’Connell of USC Norris Comprehensive Cancer Center, joined Patient Power to comment on the latest headlines in myeloproliferative neoplasms (MPNs). Dr. O’Connell shares information on interferon as well as advances in combination therapies.

Featuring

You might also like

Transcript | MPN Headlines From ASH 2018 With Dr. Casey O’Connell

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That's how you’ll get care that's most appropriate for you.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Lee Swanson:

So there's a lot of promise, but it looks like some of the impact that we were really excited to see may not start to be obvious until year three or beyond.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

You might also like